Jeanine Loncar, MD
Obstetrics & Gynecology · Madison, ALNPI 1700861713
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,846 of the $8,071 with a category attached, or 72.4%. It is spread thinly across 41 manufacturers, the largest accounting for just 20.8%. Reporting peaked in 2019 at $2,246 and has fallen 53.4% since, to $1,046 in 2025. Among obstetrics & gynecology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 315 payments — averaging $25.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Duchesnay USA Incorporated$2K
- Astellas Pharma US Inc$1K
- AbbVie$777
- Mayne Pharma Commercial LLC$385
- Pfizer$384
- Novo Nordisk$373
- plus $3K from 35 others
What the payments were for
- Speaking & faculty fees$1,50019%
- Travel & lodging$591%
- Food & beverage$5,84672%
- Education$6668%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Duchesnay USA Incorporated | 17 | $1,680 |
| Astellas Pharma US Inc | 43 | $1,107 |
| AbbVie | 46 | $777 |
| Mayne Pharma Commercial LLC | 18 | $385 |
| Pfizer | 21 | $384 |
| Novo Nordisk | 10 | $373 |
| Channel Medsystems, Inc. | 2 | $281 |
| Sumitomo Pharma America, Inc. | 15 | $269 |
| Hologic Sales And Service, LLC | 11 | $257 |
| Aspira Women's Health Inc | 4 | $252 |
| Sage Therapeutics, LLC | 13 | $240 |
| Exeltis, USA Inc. | 14 | $233 |
| Myovant Sciences Inc. | 14 | $207 |
| Meditrina | 4 | $180 |
| Bayer | 9 | $156 |
| Daiichi Sankyo Inc. | 8 | $151 |
| Millicent US Inc | 6 | $116 |
| Mylan Pharmaceuticals Inc. | 8 | $101 |
| Therapeuticsmd, Inc. | 5 | $92 |
| Lupin Inc. | 6 | $76 |
| AMAG Pharmaceuticals, Inc. | 4 | $63 |
| Organon | 4 | $60 |
| Dysis Medical, Inc. | 2 | $55 |
| Scynexis, Inc. | 3 | $51 |
| Intuitive Surgical | 1 | $49 |
| Evofem Biosciences, Inc. | 4 | $47 |
| Coopersurgical, Inc. | 2 | $40 |
| Urovant Sciences Inc | 2 | $40 |
| Smith+Nephew | 3 | $39 |
| Boston Scientific | 1 | $39 |
| Convatec Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Amgen | 2 | $33 |
| Minerva Surgical, Inc | 2 | $32 |
| BD | 1 | $30 |
| Shield Therapeutics Inc | 1 | $22 |
| Axonics, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Avion Pharmaceuticals | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,071 in reported general payments places this provider in the 90th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $10,826 |
| VeozahFezolinetant | 16 | $10,584 |
| PremarinEstrogens, Conjugated | 26 | $9,778 |
| Estradiol | 75 | $5,220 |
| PremproEstrogen,con/M-Progest Acet | 13 | $2,985 |
| ImvexxyEstradiol | 14 | $2,858 |
| OsphenaOspemifene | 11 | $2,690 |
| Raloxifene Hcl | 18 | $742 |
| Ibandronate Sodium | 12 | $741 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $651 |
| ValacyclovirValacyclovir Hcl | 21 | $619 |
| Bupropion Hcl SrBupropion Hcl | 20 | $200 |
| Fluoxetine Hcl | 27 | $188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq, Veozah | $1,107 | $21,41033 claims |
| PfizerPremarin, Prempro | $384 | $12,76339 claims |
| Therapeuticsmd, Inc.Imvexxy | $92 | $2,85814 claims |
| Duchesnay USA IncorporatedOsphena | $1,680 | $2,69011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 537 obstetrics & gynecology providers in Alabama.
Other obstetrics & gynecology in Madison
- Mark PurvisMadison$11K
- Elise ClemMadison$7K
- James TuckerMadison$7K
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Praful PatelDothan$65K
- Angela McCool-PearsonFairhope$57K
- Tomeka RobertsBirmingham$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.